Ayman S Dawood

No ORCID on file · 1 paper in corpus

rct 2017

Reduction of the cetrorelix dose in a multiple-dose antagonist protocol and its impact on pregnancy rate and affordability: A randomized controlled multicenter study

Clinical and experimental reproductive medicine ·doi:10.5653/cerm.2017.44.4.232

OBJECTIVE: To determine whether reducing the cetrorelix dose in the antagonist protocol to 0.125 mg had any deleterious effects on follicular development, the number and quality of retrieved oocytes, or the number of embryos, and to charact…